Estrogen anxiety

Rubin, Rita
April 1994
U.S. News & World Report;4/4/94, Vol. 116 Issue 13, p60
Focuses on estrogen, a widely prescribed drug for menopausal women. Evidence that estrogen therapy protects against cardiovascular disease and prevents osteoporosis; Possible increased risk of breast cancer or uterine cancer; Comments by gynecologist Edward Wallach and Elizabeth Barrett-Connor on the pros and cons of estrogen; Combination hormone therapy.


Related Articles

  • Estrogen/progesterone.  // Reactions Weekly;Sep2015, Vol. 1567 Issue 1, p92 

    The article presents case report of a patient who developed pituitary apoplexy while receiving estrogen/progesterone.

  • Estrogen therapy elevates lupus risk.  // HealthFacts;May95, Vol. 20 Issue 192, p5 

    Reports on the result of a Nurses' Health Study indicating an increase risk of developing lupus, a chronic inflammatory disorder, for postmenopausal women adhering to estrogen therapy.

  • Many women believe estrogen is harmful.  // Modern Medicine;Sep96, Vol. 64 Issue 9, p3 

    Reports on the research finding about the side effects caused by estrogen replacement therapy. Women's view about estrogen therapy.

  • Symptoms of oestrogen deficiency associated with supraphysiological plasma oestradiol concentrations in women with oestradiol implants. Gangar, Kevin; Cust, Michael; Whitehead, Malcolm I. // BMJ: British Medical Journal (International Edition);9/2/89, Vol. 298 Issue 6699, p601 

    Examines the symptoms of estrogen deficiency associated with supraphysiological plasma oestradiol concentrations in women with implants. Phenomenon of tachyphylaxis; Factors in supraphysiological oestradiol concentrations; Relief of implantation to symptoms.

  • The estrogen dilemma. Wallis, Claudia; Cole, Wendy // Time;6/26/1995, Vol. 145 Issue 26, p46 

    Examines the risks and benefits of the drug estrogen and how it is used to relieve the symptoms of menopause. How estrogen is used to slow aging; Estrogen to improve sex after menopause; Alternative solutions to estrogen use such as dietary sources; A women's family health history to assess...

  • How long should a woman take raloxifene?  // HealthFacts;Jan98, Vol. 23 Issue 1, p2 

    Raises medical concerns regarding the long-term use of the designer estrogen drug raloxifene citing the experience with similar drug Tamoxifen as cause for concern. Background on Tamoxifen.

  • Elusive estrogens may hold key to some cancer risk. Holzman, David // JNCI: Journal of the National Cancer Institute;Aug95, Vol. 87 Issue 16, p1207 

    Reports on the evidences that estrogens contribute to risk for breast cancer. Inaccuracy in the measurement of estrogen; Difficulty in conducting studies; Study conducted by Paolo Toniolo; Methodologic question about studies of premenopausal hormonal levels; Improvement of measurement technology.

  • Estradiol.  // Reactions Weekly;5/16/2009, Issue 1252, p22 

    The article describes the case of a female infant, who was diagnosed with labial agglutination at age 13 months. She was administered with betamethasone dipropionate for six weeks without effect, followed by successful treatment with conjugated estrogen cream for two weeks. Labial agglutination...

  • Conjugated estrogens.  // Reactions Weekly;11/28/2009, Issue 1280, p17 

    The article describes the case of a 31-year-old woman who experienced bloody diarrhoea and acute abdominal pain after a month of taking conjugated estrogens. An examination of the patient indicated that she had left lower quadrant tenderness and sluggish bowel sounds, while laboratory tests were...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics